Clinical Trials Directory

Trials / Unknown

UnknownNCT03288909

Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
18 (estimated)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a prospective observational study investigating the utility of 7 Tesla MRI to quantify nigrosome1 signal in a cohort of individuals with recent onset Parkinson's disease and in at-risk cohorts at a premotor state of Parkinson's disease.

Conditions

Interventions

TypeNameDescription
OTHERMRI

Timeline

Start date
2015-09-01
Primary completion
2020-01-01
Completion
2021-01-01
First posted
2017-09-20
Last updated
2019-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03288909. Inclusion in this directory is not an endorsement.

Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease (NCT03288909) · Clinical Trials Directory